ReNeuron Group plc: Clin-stage, UK-based cell therapy; allogeneic, off-the-shelf candidates: chronic stroke disability (Ph3 design approved by FDA); retinitis pigmentosa (Ph1/2 ongoing), cone rod dystrophy (Ph2 initiation); PC exosome nanomedicine platform program, first indication GMBM. GMP commercial scale cell production capability.
Website:
Address:
10 Nugent Road
Surrey Research Park
Guilford, GU2 7AF
United Kingdom

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2017 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.